Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Twinlab Faces Sale, Chapter 11 As Debt Looms

This article was originally published in The Tan Sheet

Executive Summary

Twinlab is seeking purchase offers as it faces bankruptcy due to its outstanding debts

You may also be interested in...



NBTY Aiming To Double Rexall Earnings; Closes Deal

NBTY plans to double newly acquired Rexall Sundown's earnings before interest, taxes, depreciation and amortization (EBITDA) to $78 mil. in the next nine months

Ephedra Class Action Lawsuit Requests Medical Monitoring, Product Ban

A nationwide class action lawsuit against 16 ephedra firms requests the creation of a "medical monitoring program and/or rehabilitation program" to provide medical testing and monitoring to all people who have taken ephedra-containing dietary supplements

Ephedra Product Liability Coverage Now Offered By Fewer Than 10 Insurers

Between five and 10 product liability companies have stopped offering coverage for ephedra alkaloid-containing products since June, when HHS Secretary Tommy Thompson issued a statement on ephedra's safety

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095857

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel